The latest price of acotinib medical insurance

Acalabrutinib is an oral small molecule targeted drug that belongs to the B-cell lymphoma (-2) (BTK) inhibitor class. It is widely used to treat BBcell lymphoma and other related Bcell malignancies. BTK is a key tyrosine kinase that plays an important role in the development, maturation and function of B cells.

Acotinib is now officially on sale in China and is covered by national medical insurance, allowing patients to purchase directly in China. However, its price is quite high, estimated to be about 50,000 yuan. For detailed price information and medical insurance reimbursement process, please contact your local hospital pharmacy.

In comparison, overseas generic drugs of acotinib are more affordable, especially those from Laos and Bangladesh. Specifically, the price of the Lao version of the generic drug is more than 3,000 yuan, while the Bangladeshi version is about 6,000 yuan, which is far lower than the price of the domestic original drug. It is worth mentioning that these generic drugs maintain a high degree of consistency in their pharmaceutical ingredients with the original drugs.

Acotinib blocks the key steps in the B cell receptor signaling pathway by inhibiting the activity of BTK, thereby inhibiting the growth and spread of cancer cells. Compared with traditional chemotherapy drugs, acotinib is more targeted and can destroy cancer cells more effectively while reducing damage to normal cells.

Acotinib has been widely used to treat a variety of B cell lymphomas, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), diffuse largeB cell lymphoma (DLBCL), etc. Clinical studies have shown that acotinib has good efficacy and safety in the treatment of these diseases.

In addition to monotherapy, acotinib is also used in combination with other drugs, such as anti-CD20antibodies, chemotherapy drugs, etc., to improve the efficacy. In addition, acotinib has also been studied for the treatment of other types of BB cell-related diseases, and it is still under continuous development and exploration in the clinical and scientific research fields.

However, like all drugs, acotinib also has certain side effects, common ones including headache, fatigue, high blood pressure, diarrhea, etc. During use, patients need to closely monitor their symptoms and maintain communication with their doctors so that treatment plans can be adjusted in a timely manner.